3 Takeaways From CFIUS' OK Of ChemChina-Syngenta Deal

By Benjamin Horney (August 23, 2016, 9:54 PM EDT) -- The Committee on Foreign Investment in the United States' approval of ChemChina's $43 billion acquisition of Syngenta is the largest-ever outbound Chinese acquisition, and experts say the green light bodes well for future deals that will have to be approved by the committee because CFIUS evaluates the merits of each deal without being influenced by outside factors....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!